KemPharm
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. KemPharm's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 63% to $10,458,000. Profit margin reached -397%. Total operating expenses were $34,957,000.

Profit Margin

KemPharm, Inc. (NASDAQ:KMPH): Profit margin
2013 0 -5.22M
2014 0 -24.45M
2015 0 -54.66M
2016 0 -16.51M
2017 0 -43.38M
2018 0 -56.46M
2019 12.83M -24.52M -191%
2020 13.28M -12.76M -96.03%
2021 28.65M -8.55M -29.86%
2022 10.45M -41.54M -397.24%

KMPH Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
10.45M28.65M13.28M12.83M000000
Cost of revenue
343K2.05M1.30M2.94M000000
Gross profit
10.11M26.59M11.98M9.89M000000
Operating exp.
Research and development
19.61M10.16M8.84M19.41M41.75M20.59M20.47M13.93M11.91M3.36M
Selling and marketing
0000000000
Total operating expenses
34.95M18.86M16.76M30.23M54.26M33.36M37.48M22.81M-16.44M4.71M
Operating income
-24.84M7.72M-4.78M-20.33M-55.90M-33.36M-37.48M-22.81M-16.44M-4.71M
Other income (expenses), net
-17.48M-16.25M-7.18M-4.20M-689K-10.06M20.95M-31.82M-8.03M-528K
Income before tax
-42.32M-8.52M-12.79M-24.54M-56.59M-43.42M-16.53M-54.63M-24.47M-5.24M
Income tax expense
-786K34K-34K-22K-126K-43K-15K26K-22.24K-20K
Net income
-41.54M-8.55M-12.76M-24.52M-56.46M-43.38M-16.51M-54.66M-24.45M-5.22M
Earnings per share
Basic EPS
-1.2-0.29-3.21-13.23-50.39-47.37-18.1-118.69-50.01-10.69
Diluted EPS
-1.2-0.29-3.21-13.23-50.39-47.37-18.1-118.69-50.01-10.69
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source